06/22/2026
Last week, MICYRN Director of Clinical Research, Aiman Siddiqi, attended the N2 Summit in Ottawa, joining clinical research professionals from across Canada to discuss the future of research operations and participant-centred clinical trials.
The Summit provided an opportunity to exchange ideas, explore emerging trends, strengthen connections across Canada's clinical research community, and discuss persistent challenges facing clinical trials. Topics included barriers to trial participation, operational and regulatory complexities, and the unique challenges of conducting clinical research in Canada. These conversations are critical to advancing high-quality research and ensuring children, youth, and families continue to benefit from innovative and collaborative approaches to clinical trials.
Lauren Kelly, Scientific Lead at the Children's Hospital Research Institute of Manitoba (CHRIM), spoke about some of the current challenges in pediatric clinical trials.
MICYRN is proud to be part of national dialogue and partnerships that help strengthen the clinical research landscape across Canada.
Photo (from left to right): Michelle Moldofsky, Founder, Moldofsky Professional Corporation; Aiman Siddiqi, Director of Clinical Trials, MICYRN; Daniel Morgenstern, Head of Clinical Trials, The Hospital for Sick Children, Keith McIntosh, Chair, Advocacy for Canadian Childhood Oncology Research Network (Ac2orn), ACCESS; and Kathy Brodeur Robb, Executive Director, C17 Council